These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36990742)

  • 1. MiR-640 and MiR-525-5p as Relapse-Associated MicroRNAs in Systematically Untreated Individuals with Low-Risk Primary Breast Cancer.
    Tang HH
    Tohoku J Exp Med; 2023 Jun; 260(2):171-179. PubMed ID: 36990742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-17-5p may serve as a novel predictor for breast cancer recurrence.
    Wang Y; Li J; Dai L; Zheng J; Yi Z; Chen L
    Cancer Biomark; 2018; 22(4):721-726. PubMed ID: 29914008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer.
    Papadaki C; Stratigos M; Markakis G; Spiliotaki M; Mastrostamatis G; Nikolaou C; Mavroudis D; Agelaki S
    Breast Cancer Res; 2018 Jul; 20(1):72. PubMed ID: 29996899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
    Estevão-Pereira H; Lobo J; Salta S; Amorim M; Lopes P; Cantante M; Reis B; Antunes L; Castro F; Palma de Sousa S; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
    J Transl Med; 2019 Dec; 17(1):435. PubMed ID: 31888645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer.
    Wang J; Wang S; Zhou J; Qian Q
    Biomed Pharmacother; 2018 Jun; 102():147-152. PubMed ID: 29550638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis.
    Krell J; Frampton AE; Jacob J; Pellegrino L; Roca-Alonso L; Zeloof D; Alifrangis C; Lewis JS; Jiao LR; Stebbing J; Castellano L
    Mol Diagn Ther; 2012 Jun; 16(3):167-72. PubMed ID: 22489664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of miR-199b-5p is correlated with poor prognosis for breast cancer patients.
    Fang C; Wang FB; Li Y; Zeng XT
    Biomed Pharmacother; 2016 Dec; 84():1189-1193. PubMed ID: 27788476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-4732-5p promotes breast cancer progression by targeting TSPAN13.
    Wang YW; Zhao S; Yuan XY; Liu Y; Zhang K; Wang J; Zhu J; Ma R
    J Cell Mol Med; 2019 Apr; 23(4):2549-2557. PubMed ID: 30701690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
    Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
    Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-188-5p suppresses cellular proliferation and migration via IL6ST: A potential noninvasive diagnostic biomarker for breast cancer.
    Wang M; Zhang H; Yang F; Qiu R; Zhao X; Gong Z; Yu W; Zhou B; Shen B; Zhu W
    J Cell Physiol; 2020 May; 235(5):4890-4901. PubMed ID: 31650530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of miR-1247-5p expression with clinicopathological parameters and prognosis in breast cancer.
    Zhang P; Fan C; Du J; Mo X; Zhao Q
    Int J Exp Pathol; 2018 Aug; 99(4):199-205. PubMed ID: 30175411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-145-5p as a predictive biomarker for breast cancer stemness by computational clinical investigation.
    Rajarajan D; Kaur B; Penta D; Natesh J; Meeran SM
    Comput Biol Med; 2021 Aug; 135():104601. PubMed ID: 34186326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer.
    Li Z; Lin C; Zhao L; Zhou L; Pan X; Quan J; Peng X; Li W; Li H; Xu J; Xu W; Guan X; Chen Y; Lai Y
    Biomed Pharmacother; 2018 Sep; 105():461-469. PubMed ID: 29883941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A microRNA signature associated with early recurrence in breast cancer.
    Pérez-Rivas LG; Jerez JM; Carmona R; de Luque V; Vicioso L; Claros MG; Viguera E; Pajares B; Sánchez A; Ribelles N; Alba E; Lozano J
    PLoS One; 2014; 9(3):e91884. PubMed ID: 24632820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease.
    Tsiakanikas P; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
    Clin Chem Lab Med; 2018 May; 56(6):990-1000. PubMed ID: 29688883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
    Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
    J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
    Qin H; Liu W
    J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer.
    Zhang J; Kong X; Shi Q; Zhao B
    Cancer Biomark; 2020; 27(4):423-432. PubMed ID: 31903982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway.
    Lee J; Kim HE; Song YS; Cho EY; Lee A
    Breast Cancer Res Treat; 2019 Jul; 176(1):119-130. PubMed ID: 30989460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.